Mindbio Therapeutics Corp. (TSE:MBIO) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MindBio Therapeutics Corp. has announced a significant financial move as Riverfort Global Opportunities PCC Ltd has agreed to convert a CAD$100,000 loan into 2,000,000 shares of MindBio at $0.05 each, with a four-month hold period. The company is at the forefront of mental health treatment innovation, conducting pioneering take-home microdosing clinical trials with its leading drug candidate, MB22001, a unique form of LSD tailored for microdosing purposes.
For further insights into TSE:MBIO stock, check out TipRanks’ Stock Analysis page.